Full name
EMPIRE PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.45.Z - Wholesale of perfume and cosmetics
20.42.Z - Manufacture of perfumes and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
68.20.Z - Rental and operating of own or leased real estate
70.22.Z - Business and other management consultancy activities
77.12.Z - Rental and leasing of other motor vehicle, excluding motorcycles
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,6 | 2,2 | 0,5 | -78,5 |
Gross profit (loss) | 1,6 | 1,7 | -0,6 | -138 |
EBITDA | 1,5 | 1,9 | -0,3 | -118,2 |
Short time liabilities | 2,1 | 2,8 | 6 | 110,6 |
Other operating costs | 1,6 | 1 | 1 | 9,1 |
Equity capital | 3,5 | 3,8 | 2,4 | -37,4 |
Operating profit (EBIT) | 1,5 | 1,7 | -0,4 | -122,6 |
Assets | 5,6 | 6,6 | 9,3 | 41,8 |
Net profit (loss) | 1,2 | 1,3 | -0,6 | -147,7 |
Cash | 0 | 0,5 | 0,5 | 1,6 |
Net income from sale | 15,8 | 22,5 | 27,8 | 23,8 |
Liabilities and provisions for liabilities | 2,1 | 2,8 | 7 | 147,1 |
Working assets | 5,5 | 6,3 | 7,8 | 22,5 |
Other income costs | 0,5 | 0,5 | 0,2 | -62,3 |
Depreciation | 0 | 0,2 | 0 | -67,4 |
% | % | % | p.p. | |
Profitability of capital | 33,9 | 35,2 | -26,9 | -62,1 |
Equity capital to total assets | 62,8 | 57 | 25,2 | -31,8 |
Gross profit margin | 10 | 7,4 | -2,3 | -9,7 |
EBITDA Margin | 9,7 | 8,4 | -1,2 | -9,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 48 | 46 | 78 | 32 |
Current financial liquidity indicator | 2.608680009841919 | 2.2437379360198975 | 1.3045827150344849 | -0,9 |
Net dept to EBITDA | 0.044093113392591476 | -0.1711650788784027 | -5.728504180908203 | -5,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane